The global fertility tourism market accounted for USD 0.709 billion in 2023 and is expected to reach at USD 13.08 billion by 2034 with a CAGR of 30.34% during the forecast period 2024-2034. Rising prevalence of infertility, surge in delayed pregnancies, rapid uptake of medical tourism, growing advancements in assisted reproductive technologies, increase in report tourism, rise in both male & female infertility cases, surge in average age of marriage & first-time parenthood, more women are seeking treatment abroad, higher numbers & success rates of IVF procedures, growing investment from both public & private sectors in new clinics & fertility centers, and increasing initiatives by market players to launch medical tourism are some of the key factors boosting the market growth.
Increasing initiatives by market players to launch medical tourism is predicted to boost the market growth during the forecast period. Fertility tourism involves individuals traveling to another country for fertility treatment, also known as medical or reproductive tourism. Various factors can drive fertility tourism, including cost savings and additional benefits such as improved healthcare, advanced technology, excellent hospitality, and individualized care, which attract visitors. For instance, in January 2024, Ferns N Petals revealed the introduction of MediJourney, a new division focusing on medical tourism. The company emphasized that MediJourney is dedicated to prioritizing personalized wellness for people across the globe.
By service, in-vitro fertilization was the highest revenue-grossing segment in the global fertility tourism market in 2023 owing to the rising trend of postponed pregnancies, increase in the success rate of IVF procedures, and expansion of efforts by industry leaders. For instance, in September 2023, Merck, a prominent science and technology firm, is introducing an extensive Fertility Benefit program, providing financial assistance to employees for fertility treatments. Currently, Merck extends similar benefits to its employees in the United States, Canada, and Japan. Additionally, artificial insemination is predicted to grow at the fastest CAGR during the forecast period owing to the growing incidence of infertility problems and continuous advancements in AI methods, including intrauterine insemination (IUI).
By application, sex selection was the highest revenue-grossing segment in the global fertility tourism market in 2023 owing to the availability of gender selection as an option in in-vitro fertilization (IVF) treatments and growing technological advancements. Additionally, infertility treatment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for advanced infertility treatments such as assisted reproductive technology, and rise in the number of fertility clinics. For instance, in March 2024, TMRW Life Sciences (TMRW), a fertility technology company revolutionizing IVF laboratory standards, has unveiled CryoLink, a workstation designed to streamline the digital organization of frozen specimen inventory for fertility clinics. The introduction of CryoLink allows the utilization of TMRW's Digital Specimen Management system independently or in conjunction with TMRW's automated storage platforms.
By age group, 35-44 was the highest revenue-grossing segment in the global fertility tourism market in 2023 owing to the rise in infertility rates within this demographic, increased accessibility to a wider pool of donors from international clinics, the advertised success rates, and growing trend of collaborations among industry stakeholders to offer more advanced treatment alternatives. The primary factors driving travel for assisted reproductive technology (ART) treatments include cost and the desire for anonymity. Moreover, advancing age elevates the risk of pregnancy complications such as cesarean section, placenta previa, gestational diabetes, and stillbirth. For instance, in May 2023, INVO Bioscience Inc. and Ming Mei Technology have recently entered into an exclusive distribution agreement for the INVOcell intravaginal culture (IVC) system. This partnership is expected to offer individuals in Taiwan access to state-of-the-art assisted reproductive treatments. Additionally, 45-54 is anticipated to grow at the fastest CAGR during the forecast period. Countries with robust regulatory systems attract patients aged 45-54 due to their ample financial resources and advanced treatment facilities, leading to a surge in patient numbers.
By end-users, female was the highest revenue-grossing segment in the global fertility tourism market in 2023 owing to the increase in infertility cases, rising awareness about the range of available treatment options, and growing number of advanced fertility centers being established. For instance, in March 2022, Birla Fertility and IVF Center inaugurated its cutting-edge IVF facility in Dwarka, India, providing comprehensive fertility diagnostic, assessment, and treatment services for both genders. Additionally, male is predicted to grow at the fastest CAGR during the forecast period owing to the factors such as reduced sperm concentration, abnormal morphology, & diminished sperm motility, rising awareness of male infertility, growing demand for hormonal therapy, and increasing uptake of DNA fragmentation diagnostic techniques.
Asia-Pacific region is anticipated for the highest revenue share during the forecast period owing to the accessibility of world-class IVF treatment services at reduced costs, increase in medical tourists, establishment of more fertility clinics, growing number of Chinese couples seeking IVF treatment abroad, increasing government initiatives to launch fertility clinics in popular medical tourism destinations to cater to the rising demand for fertility treatments. For instance, in December 2022, The Karnataka government has announced its intention to establish in vitro fertilization (IVF) clinics within government hospitals as a means to address the expenses associated with undergoing such procedures at private clinics. Additionally, North America region is predicted to grow at fastest CAGR during the forecast period owing to the growing patient population, rapid advancements in fertility tourism, increasing presence of international fertility clinics, rise in private institutions, and surge in initiatives from key market players. For instance, in October 2022, Ferring Pharmaceuticals introduced FertilityWise, an online series of e-learning modules designed for fertility nurses and advanced practice providers. This platform provides both new and experienced staff members with free access to a comprehensive online library covering topics such as reproductive endocrinology, cryopreservation, and embryo development.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Increasing initiatives by market players to launch medical tourism is predicted to boost the market growth during the forecast period. Fertility tourism involves individuals traveling to another country for fertility treatment, also known as medical or reproductive tourism. Various factors can drive fertility tourism, including cost savings and additional benefits such as improved healthcare, advanced technology, excellent hospitality, and individualized care, which attract visitors. For instance, in January 2024, Ferns N Petals revealed the introduction of MediJourney, a new division focusing on medical tourism. The company emphasized that MediJourney is dedicated to prioritizing personalized wellness for people across the globe.
By service, in-vitro fertilization was the highest revenue-grossing segment in the global fertility tourism market in 2023 owing to the rising trend of postponed pregnancies, increase in the success rate of IVF procedures, and expansion of efforts by industry leaders. For instance, in September 2023, Merck, a prominent science and technology firm, is introducing an extensive Fertility Benefit program, providing financial assistance to employees for fertility treatments. Currently, Merck extends similar benefits to its employees in the United States, Canada, and Japan. Additionally, artificial insemination is predicted to grow at the fastest CAGR during the forecast period owing to the growing incidence of infertility problems and continuous advancements in AI methods, including intrauterine insemination (IUI).
By application, sex selection was the highest revenue-grossing segment in the global fertility tourism market in 2023 owing to the availability of gender selection as an option in in-vitro fertilization (IVF) treatments and growing technological advancements. Additionally, infertility treatment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for advanced infertility treatments such as assisted reproductive technology, and rise in the number of fertility clinics. For instance, in March 2024, TMRW Life Sciences (TMRW), a fertility technology company revolutionizing IVF laboratory standards, has unveiled CryoLink, a workstation designed to streamline the digital organization of frozen specimen inventory for fertility clinics. The introduction of CryoLink allows the utilization of TMRW's Digital Specimen Management system independently or in conjunction with TMRW's automated storage platforms.
By age group, 35-44 was the highest revenue-grossing segment in the global fertility tourism market in 2023 owing to the rise in infertility rates within this demographic, increased accessibility to a wider pool of donors from international clinics, the advertised success rates, and growing trend of collaborations among industry stakeholders to offer more advanced treatment alternatives. The primary factors driving travel for assisted reproductive technology (ART) treatments include cost and the desire for anonymity. Moreover, advancing age elevates the risk of pregnancy complications such as cesarean section, placenta previa, gestational diabetes, and stillbirth. For instance, in May 2023, INVO Bioscience Inc. and Ming Mei Technology have recently entered into an exclusive distribution agreement for the INVOcell intravaginal culture (IVC) system. This partnership is expected to offer individuals in Taiwan access to state-of-the-art assisted reproductive treatments. Additionally, 45-54 is anticipated to grow at the fastest CAGR during the forecast period. Countries with robust regulatory systems attract patients aged 45-54 due to their ample financial resources and advanced treatment facilities, leading to a surge in patient numbers.
By end-users, female was the highest revenue-grossing segment in the global fertility tourism market in 2023 owing to the increase in infertility cases, rising awareness about the range of available treatment options, and growing number of advanced fertility centers being established. For instance, in March 2022, Birla Fertility and IVF Center inaugurated its cutting-edge IVF facility in Dwarka, India, providing comprehensive fertility diagnostic, assessment, and treatment services for both genders. Additionally, male is predicted to grow at the fastest CAGR during the forecast period owing to the factors such as reduced sperm concentration, abnormal morphology, & diminished sperm motility, rising awareness of male infertility, growing demand for hormonal therapy, and increasing uptake of DNA fragmentation diagnostic techniques.
Asia-Pacific region is anticipated for the highest revenue share during the forecast period owing to the accessibility of world-class IVF treatment services at reduced costs, increase in medical tourists, establishment of more fertility clinics, growing number of Chinese couples seeking IVF treatment abroad, increasing government initiatives to launch fertility clinics in popular medical tourism destinations to cater to the rising demand for fertility treatments. For instance, in December 2022, The Karnataka government has announced its intention to establish in vitro fertilization (IVF) clinics within government hospitals as a means to address the expenses associated with undergoing such procedures at private clinics. Additionally, North America region is predicted to grow at fastest CAGR during the forecast period owing to the growing patient population, rapid advancements in fertility tourism, increasing presence of international fertility clinics, rise in private institutions, and surge in initiatives from key market players. For instance, in October 2022, Ferring Pharmaceuticals introduced FertilityWise, an online series of e-learning modules designed for fertility nurses and advanced practice providers. This platform provides both new and experienced staff members with free access to a comprehensive online library covering topics such as reproductive endocrinology, cryopreservation, and embryo development.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Service, Application, Age Group, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Fertility Tourism Market Report 2023 - 2034
Fertility Tourism Market Analysis & Forecast by Service 2023 - 2034 (Revenue USD Bn)
- Artificial Insemination
- In-Vitro Fertilization
- Others
Fertility Tourism Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Sex Selection
- Infertility Treatment
- Others
Fertility Tourism Market Analysis & Forecast by Age Group 2023 - 2034 (Revenue USD Bn)
- 18 - 24
- 25 - 34
- 34 - 44
- 46 - 54
Fertility Tourism Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Male
- Female
Fertility Tourism Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Fertility Tourism Market: Service Estimates & Trend Analysis
8. Fertility Tourism Market: Application Estimates & Trend Analysis
9. Fertility Tourism Market: Age Group Estimates & Trend Analysis
10. Fertility Tourism Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Fertility Tourism Market
13. Europe Global Fertility Tourism Market
14. Asia Pacific Global Fertility Tourism Market
15. Latin America Global Fertility Tourism Market
16. MEA Global Fertility Tourism Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Assisted Reproduction and Gynecology Centre
- Bumrungrad International Hospital
- Alpha IVF & Women’s Specialists
- Manchester Fertility Services Ltd
- San Diego Fertility Center
- The Surrey Park Clinic
- Eva Fertility Clinics
- Sincere IVF Center
- Barcelona IVF
- Apollo Fertility
- Genesis IVF
- IVF-Life
